{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:24:46Z","timestamp":1790036686288,"version":"4.0.1"},"reference-count":51,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":1635,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.virol.2008.12.012","type":"journal-article","created":{"date-parts":[[2009,1,21]],"date-time":"2009-01-21T13:31:26Z","timestamp":1232544686000},"page":"409-415","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":81,"title":["Vaccination with virus-like particles protects mice from lethal infection of Rift Valley Fever Virus"],"prefix":"10.1016","volume":"385","author":[{"given":"Jonas","family":"N\u00e4slund","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Lagerqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Habjan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c5ke","family":"Lundkvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Evander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clas","family":"Ahlm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedemann","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6ran","family":"Bucht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2008.12.012_bib1","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1086\/345671","article-title":"Epidemic Rift Valley fever in Saudi Arabia: a clinical study of severe illness in humans","volume":"36","author":"Al-Hazmi","year":"2003","journal-title":"Clin. Infect. Dis."},{"issue":"Suppl 2","key":"10.1016\/j.virol.2008.12.012_bib2","first-page":"169","article-title":"Summary of clinical findings on Engerix-B, a genetically engineered yeast derived hepatitis B vaccine","volume":"63","author":"Andr\u00e9","year":"1987","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.virol.2008.12.012_bib3","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0924-8579(02)00295-9","article-title":"Rift Valley fever: an uninvited zoonosis in the Arabian peninsula","volume":"21","author":"Balkhy","year":"2003","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.virol.2008.12.012_bib4","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1016\/S0264-410X(03)00308-6","article-title":"Immunogenicity and protective efficacy of rotavirus 2\/6-virus-like particles produced by a dual baculovirus expression vector and administered intramuscularly, intranasally, or orally to mice","volume":"21","author":"Bertolotti-Ciarlet","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2008.12.012_bib5","doi-asserted-by":"crossref","first-page":"9798","DOI":"10.1128\/JVI.78.18.9798-9806.2004","article-title":"NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription","volume":"78","author":"Billecocq","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2008.12.012_bib6","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.virol.2008.05.033","article-title":"RNA polymerase I-mediated expression of viral RNA for the rescue of infectious virulent and avirulent Rift Valley fever viruses","volume":"378","author":"Billecocq","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.virol.2008.12.012_bib7","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1128\/JVI.02501-07","article-title":"Rift valley fever virus lacking the NSs and NSm genes is highly attenuated, confers protective immunity from virulent virus challenge, and allows for differential identification of infected and vaccinated animals","volume":"82","author":"Bird","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2008.12.012_bib8","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/jmv.20624","article-title":"Adverse response of non-indigenous cattle of European breeds to live attenuated Smithburn Rift Valley fever vaccine","volume":"78","author":"Botros","year":"2006","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.virol.2008.12.012_bib9","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1099\/0022-1317-66-10-2271","article-title":"Mutagen-directed attenuation of Rift Valley fever virus as a method for vaccine development","volume":"66","author":"Caplen","year":"1985","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2008.12.012_bib10","first-page":"119","article-title":"Hydrops amnii in sheep associated with hydranencephaly and arthrogryposis with wesselsbron disease and rift valley fever viruses as aetiological agents","volume":"44","author":"Coetzer","year":"1977","journal-title":"Onderstepoort J. Vet. Res."},{"key":"10.1016\/j.virol.2008.12.012_bib11","doi-asserted-by":"crossref","first-page":"5945","DOI":"10.1128\/jvi.68.9.5945-5952.1994","article-title":"Characterization of virus-like particles produced by the expression of rotavirus capsid proteins in insect cells","volume":"68","author":"Crawford","year":"1994","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2008.12.012_bib12","series-title":"\u201cThe Bunyaviridae.\u201d The Viruses","author":"Elliott","year":"1996"},{"key":"10.1016\/j.virol.2008.12.012_bib13","doi-asserted-by":"crossref","first-page":"827","DOI":"10.2174\/156652405774962263","article-title":"Rift Valley fever virus","volume":"5","author":"Flick","year":"2005","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.virol.2008.12.012_bib14","doi-asserted-by":"crossref","first-page":"613","DOI":"10.20506\/rst.23.2.1500","article-title":"Rift Valley fever","volume":"23","author":"Gerdes","year":"2004","journal-title":"Rev. Sci. Tech."},{"key":"10.1016\/j.virol.2008.12.012_bib15","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.virol.2006.09.035","article-title":"The NSm proteins of Rift Valley fever virus are dispensable for maturation, replication and infection","volume":"359","author":"Gerrard","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.virol.2008.12.012_bib16","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ymeth.2006.07.018","article-title":"Virus-like particles: passport to immune recognition","volume":"40","author":"Grgacic","year":"2006","journal-title":"Methods"},{"key":"10.1016\/j.virol.2008.12.012_bib17","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1099\/vir.0.2008\/002097-0","article-title":"T7 RNA polymerase-dependent and -independent systems for cDNA-based rescue of Rift Valley fever virus","volume":"89","author":"Habjan","year":"2008","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2008.12.012_bib18","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.virol.2008.12.011","article-title":"Efficient production of Rift Valley fever virus-like particles: the antiviral protein MxA can inhibit primary transcription of Bunyaviruses","volume":"385","author":"Habjan","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.virol.2008.12.012_bib19","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/S0140-6736(06)68439-0","article-title":"Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial","volume":"367","author":"Harper","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.virol.2008.12.012_bib20","first-page":"95","article-title":"Teratogenicity of a mutagenised Rift Valley fever virus (MVP 12) in sheep","volume":"69","author":"Hunter","year":"2002","journal-title":"Onderstepoort J. Vet. Res."},{"key":"10.1016\/j.virol.2008.12.012_bib21","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1128\/JVI.80.6.2933-2940.2006","article-title":"Rescue of infectious rift valley fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign gene","volume":"80","author":"Ikegami","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2008.12.012_bib22","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jviromet.2006.11.005","article-title":"Preparation and evaluation of a recombinant Rift Valley fever virus N protein for the detection of IgG and IgM antibodies in humans and animals by indirect ELISA","volume":"140","author":"Jansen van Vuren","year":"2007","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.virol.2008.12.012_bib23","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/oxfordjournals.aje.a113471","article-title":"A Rift Valley fever vaccine trial. I. Side effects and serologic response over a six-month follow-up","volume":"116","author":"Kark","year":"1982","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.virol.2008.12.012_bib24","doi-asserted-by":"crossref","first-page":"12180","DOI":"10.1073\/pnas.89.24.12180","article-title":"Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic","volume":"89","author":"Kirnbauer","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.virol.2008.12.012_bib25","doi-asserted-by":"crossref","first-page":"6154","DOI":"10.1128\/JVI.75.13.6154-6165.2001","article-title":"Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins","volume":"75","author":"Latham","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2008.12.012_bib26","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0092-8674(04)00132-1","article-title":"TFIIH transcription factor, a target for the Rift Valley hemorrhagic fever virus","volume":"116","author":"Le May","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.virol.2008.12.012_bib27","doi-asserted-by":"crossref","first-page":"11974","DOI":"10.1128\/JVI.79.18.11974-11980.2005","article-title":"The N terminus of Rift Valley fever virus nucleoprotein is essential for dimerization","volume":"79","author":"Le May","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2008.12.012_bib28","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/j.vaccine.2006.09.082","article-title":"Cross-reactive immune responses in mice after genetic vaccination with cDNA encoding hantavirus nucleocapsid proteins","volume":"25","author":"Lindkvist","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2008.12.012_bib29","doi-asserted-by":"crossref","first-page":"179","DOI":"10.20506\/rst.26.1.1737","article-title":"Veterinary vaccines and their use in developing countries","volume":"26","author":"Lubroth","year":"2007","journal-title":"Rev. Sci. Tech."},{"key":"10.1016\/j.virol.2008.12.012_bib30","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/01.AOG.0000192397.41191.fb","article-title":"Efficacy of human papillomavirus-16 vaccine to prevent cervical intraepithelial neoplasia: a randomized controlled trial","volume":"107","author":"Mao","year":"2006","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.virol.2008.12.012_bib31","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/307178a0","article-title":"Human hepatitis B vaccine from recombinant yeast","volume":"307","author":"McAleer","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.virol.2008.12.012_bib32","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/0035-9203(79)90004-X","article-title":"The Rift Valley fever epizootic in Egypt 1977\u201378. 1. Description of the epizootic and virological studies","volume":"73","author":"Meegan","year":"1979","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.virol.2008.12.012_bib33","series-title":"Foreign Animal Diseases","first-page":"369","author":"Metwally","year":"2008"},{"issue":"10","key":"10.1016\/j.virol.2008.12.012_bib51","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.2460\/ajvr.1997.58.10.1104","article-title":"Safety and efficacy of a mutagen-attenuated Rift Valley fever virus vaccine in cattle","volume":"58","author":"Morrill","year":"1997","journal-title":"Am J Vet Res."},{"key":"10.1016\/j.virol.2008.12.012_bib34","doi-asserted-by":"crossref","first-page":"405","DOI":"10.4269\/ajtmh.1995.53.405","article-title":"Characterization of clone 13, a naturally attenuated avirulent isolate of Rift Valley fever virus, which is altered in the small segment","volume":"53","author":"Muller","year":"1995","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.virol.2008.12.012_bib35","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jviromet.2008.04.007","article-title":"Kinetics of Rift Valley Fever Virus in experimentally infected mice using quantitative real-time RT-PCR","volume":"151","author":"N\u00e4slund","year":"2008","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.virol.2008.12.012_bib36","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0264-410X(99)00218-2","article-title":"Immunogenicity of an inactivated Rift Valley fever vaccine in humans: a 12-year experience","volume":"18","author":"Pittman","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2008.12.012_bib37","doi-asserted-by":"crossref","first-page":"5751","DOI":"10.1016\/j.vaccine.2005.07.098","article-title":"Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB\/c mice","volume":"23","author":"Pushko","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2008.12.012_bib38","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1007\/s00705-006-0923-8","article-title":"Neutralization of animal virus infectivity by antibody","volume":"152","author":"Reading","year":"2007","journal-title":"Arch. Virol."},{"key":"10.1016\/j.virol.2008.12.012_bib39","doi-asserted-by":"crossref","first-page":"8196","DOI":"10.1128\/JVI.73.10.8196-8200.1999","article-title":"Genetic reassortment of Rift Valley fever virus in nature","volume":"73","author":"Sall","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2008.12.012_bib40","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1136\/bjo.64.5.366","article-title":"Rift Valley fever ocular manifestations: observations during the 1977 epidemic in Egypt","volume":"64","author":"Siam","year":"1980","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.virol.2008.12.012_bib41","first-page":"1","article-title":"Rift Valley Fever: the neurotropic adaptation of the virus and the experimental use of this modified virus as a vaccine","volume":"1","author":"Smithburn","year":"1949","journal-title":"Br. J. Exp. Pathol."},{"key":"10.1016\/j.virol.2008.12.012_bib42","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1016\/j.vaccine.2004.11.070","article-title":"Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections","volume":"23","author":"Swenson","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2008.12.012_bib43","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0168-1656(99)00121-2","article-title":"Diva vaccines that reduce virus transmission","volume":"73","author":"van Oirschot","year":"1999","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.virol.2008.12.012_bib44","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0168-1702(97)00097-X","article-title":"Mapping of the mutations present in the genome of the Rift Valley fever virus attenuated MP12 strain and their putative role in attenuation","volume":"52","author":"Vialat","year":"1997","journal-title":"Virus Res."},{"key":"10.1016\/j.virol.2008.12.012_bib45","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jbiotec.2005.03.026","article-title":"Triple layered rotavirus VLP production: kinetics of vector replication, mRNA stability and recombinant protein production","volume":"120","author":"Vieira","year":"2005","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.virol.2008.12.012_bib46","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1470-2045(05)70101-7","article-title":"Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial","volume":"6","author":"Villa","year":"2005","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.virol.2008.12.012_bib47","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1016\/j.vaccine.2004.01.063","article-title":"Marburg virus-like particles protect guinea pigs from lethal Marburg virus infection","volume":"22","author":"Warfield","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2008.12.012_bib48","doi-asserted-by":"crossref","first-page":"13335","DOI":"10.1128\/JVI.01238-07","article-title":"NSm protein of Rift Valley fever virus suppresses virus-induced apoptosis","volume":"81","author":"Won","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2008.12.012_bib49","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jviromet.2005.07.002","article-title":"Production of monoclonal antibodies against Rift Valley fever virus Application for rapid diagnosis tests (virus detection and ELISA) in human sera","volume":"131","author":"Zaki","year":"2006","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.virol.2008.12.012_bib50","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0042-6822(91)90772-4","article-title":"Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles","volume":"185","author":"Zhou","year":"1991","journal-title":"Virology"}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682208008106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682208008106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T23:58:29Z","timestamp":1758585509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682208008106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0042682208008106"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2008.12.012","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccination with virus-like particles protects mice from lethal infection of Rift Valley Fever Virus","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2008.12.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}